deltatrials
Completed PHASE4 NCT00228384

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease

Sponsor: W.L.Gore & Associates

Conditions Peripheral Vascular Diseases
Interventions Bare Nitinol Stent GORE VIABAHN Endoprosthesis
Updated 7 times since 2017 Last updated: May 25, 2012 Started: Sep 30, 2005 Primary completion: Jan 31, 2011 Completion: Jan 31, 2011

This PHASE4 trial investigates Peripheral Vascular Diseases and is currently completed. W.L.Gore & Associates leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • W.L.Gore & Associates
Data source: W.L.Gore & Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austell, United States, Beaver, United States, Cleveland, United States, Columbus, United States, Fort Lauderdale, United States, Little Rock, United States, Lombard, United States, Melrose Park, United States, Milwaukee, United States, New Orleans, United States and 5 more location s